Quality of Life of Frail Aged Patients in Incremental Hemodialysis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

783 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-09

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

End stage renal disease (ESRD) is a major public health problem. The dialysis population is aging. As a result we observe a high prevalence of frailty among dialysis patients (ranges from 3 to 10 fold higher than in the comparably aged general public). Frailty is a medical syndrome characterized by diminished strength, endurance, and reduced physiologic function that increases an individual's vulnerability for developing increased dependency and/or death. Without systematic approach it is difficult for physicians to detect frailty phenotype which however might be reversible or attenuated by interventions. Fried et al. developed a frailty phenotype consisting of 3 or more of: unintentional weight loss, exhaustion, physical inactivity, slow gait speed, and weak grip strength. The primary care of hemodialysis patient is often supported by the nephrologist. Identification of frailty is integrated into the primary care setting as one of the steps necessary for the overall assessment of the person and planning to formal prevention interventions in an individualized care plan. Thrice-weekly hemodialysis (HD) schedules are the standard default hemodialysis prescription in Western countries, imposed in the 70s. For incremental HD, the weekly dose of dialysis is based on variety of clinical factors such as residual kidney function, volume status, cardiovascular symptoms, potassium level, nutritional status and, comorbid conditions. Incremental HD scheme generally starts with 2 weekly sessions and then periodic monitoring of criteria mentioned above are used to determine the timing for increasing dialysis dose and frequency to 3 weekly sessions.

An approach that integrates systematic frailty phenotype assessment by nephrologists and individualized incremental HD therapy can be beneficial within the first year of HD. It could optimize health-related quality of life and other pertinent outcomes without affecting negatively the quality of dialysis. The purpose of this study is to evaluate for frail aged incidents hemodialysis patients the impact of implementation of an incremental HD on HRQoL compared to conventional HD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Frailty Intervention Trial in End-Stage Patients on Dialysis

NCT03071107

Hemodialysis Complication Nutritional Deficiency Physical Activity

UNKNOWN NA

Muscle Wasting in Hemodialysis Patient

NCT03583177

Muscle Atrophy in Lung Cancer and Hemodialysed Patients

COMPLETED

Comparison of Daily Home Hemodialysis (HD) With Conventional in Center HD in Terms of Patients Quality of Life and Clinical Outcomes

NCT03737578

End Stage Renal Disease

UNKNOWN NA

Muscle Mass or Muscle Function as a prédictive Tools for Outtcomme in Chronic Dialysis Patients

NCT03845452

Chrnoic Haemodialysis Patients

COMPLETED

Intradialytic Exercise and Remote Ischaemic Preconditioning: a Cardioprotective Role ?

NCT06856512

Hemodialysis

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Dialysis Kidney Failure, Chronic Frailty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Incremental hemodialysis

Patients who will begin HD with two treatment sessions per week

Group Type EXPERIMENTAL

Dialysis frequency reduction

Intervention Type OTHER

At initiation, frequency of dialysis will be reduced to 2 weekly sessions (incremental HD)

Frailty diagnosis

Intervention Type OTHER

Before randomization, we will determine whether patients are frail. We will define frailty as the presence of at least three of the following five conditions: malnourished according to dietitian assessment and/or short form of Mini Nutritional Assessment (MNA), grip strength and gait speed using participants' scores on the SF-36 Physical Functioning (PF) scale, exhaustion using in the quality of life questionnaire SF-36 vitality (VT) scale and physical activity according to patient assessment (one single question)

Conventional hemodialysis

Patients who will begin HD three times a week

Group Type ACTIVE_COMPARATOR

Frailty diagnosis

Intervention Type OTHER

Before randomization, we will determine whether patients are frail. We will define frailty as the presence of at least three of the following five conditions: malnourished according to dietitian assessment and/or short form of Mini Nutritional Assessment (MNA), grip strength and gait speed using participants' scores on the SF-36 Physical Functioning (PF) scale, exhaustion using in the quality of life questionnaire SF-36 vitality (VT) scale and physical activity according to patient assessment (one single question)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dialysis frequency reduction

At initiation, frequency of dialysis will be reduced to 2 weekly sessions (incremental HD)

Intervention Type OTHER

Frailty diagnosis

Before randomization, we will determine whether patients are frail. We will define frailty as the presence of at least three of the following five conditions: malnourished according to dietitian assessment and/or short form of Mini Nutritional Assessment (MNA), grip strength and gait speed using participants' scores on the SF-36 Physical Functioning (PF) scale, exhaustion using in the quality of life questionnaire SF-36 vitality (VT) scale and physical activity according to patient assessment (one single question)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For all patients (incident HD patients):

* Patient aged over 60 years
* Signature of informed consent
* Affiliation to a French social security or receiving such a scheme
* Patient with Chronic Kidney Disease Stage 5 (GFR \<15 ml/min/1.73m2)
* Urine output \> 0,5 L per day
* Kru ≥ 2 ml/min
* Outpatient with scheduled start of HD
* Understand and read french

For randomized patients (frail incident HD patients):

\- Frailty according to L. Fried criteria: score greater than or equal to 3/5

Exclusion Criteria

* Inability to understand the reasons for the study; psychiatric disorders
* Active and/or treated neoplastic disease
* Scheduled kidney transplantation within 6 months
* Solid organ transplanted patient receiving immunosuppressive therapy
* Estimated life expectancy \< 6 months
* Patient with diagnosis of severe chronic heart failure (\> 2 congestive heart failure episodes requiring hospitalization in the year preceding the start of HD)
* Legal disability or limited legal capacity
* Patient without health insurance
* Pregnant
* Patient in the period of exclusion of another study
* Uncooperative patient

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No